Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

What Do Diabetes, Islet Cells & Autoimmunity Have in Common?

Simon M. Helfgott, MD  |  Issue: August 2017  |  August 15, 2017

“Man may be the captain of his fate, but he is also the victim of his blood sugar.” —Wilfrid Oakley, MB BChir, an early pioneer in diabetes care

Perusing the list of the most notable medical achievements in the 20th century, a reader may conclude that the discovery of insulin should rank in a category by itself. Consider some of its competitors: penicillin, discovered by Sir Alexander Fleming, MBBS, a brilliant Scottish bacteriologist noted for his original thinking and technical ingenuity throughout his illustrious career; the polio vaccine developed by Jonas Salk, MD, who had long studied viral diseases and focused his career on this particular virus for several years before his groundbreaking discovery; or the DNA double-helix structure discovered by a gifted, varied group of investigators working at Cambridge University in England, including James Watson, PhD (zoologist), Francis Crick, PhD (biologist), and Rosalind Franklin, PhD (chemist).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In stark contrast, consider the two people whose names are inextricably linked with the discovery of insulin: Frederick Banting, MD, was a struggling orthopedic surgeon who, for financial reasons, abandoned a fledgling private practice in London, Ontario, Canada, to pursue research in diabetes despite his lack of any formal training in the topic, and Charles Best, a 22-year-old medical student at the University of Toronto, Ontario, who was vying with a classmate to work on this project and succeeded by winning a determining coin toss.1 (Interestingly, decades later, the losing student, E. Clark Noble, MD, had a second brush with fame, when he was mailed a bag of leaves from a Jamaican plant by a patient who was visiting the island and had heard about their medicinal effects on diabetes. Dr. Clark Noble passed them along to his brother, Robert Noble, MD, who directed a research lab at the University of Western Ontario in London. The leaf extracts showed little effect on blood glucose levels, but significantly suppressed bone marrow tissue. Subsequent work identified the primary ingredient as the vinca alkaloid, vinblastine, which remains a mainstay in cancer chemotherapy.)

Dr. Banting and Mr. Best were hardly the first investigators to try to extract the hormone responsible for glucose regulation from the pancreas. Prior efforts to inject subjects with crude pancreatic extracts were abject failures that led to abscess formation and fatal infections. These concoctions were loaded with the digestive enzymes, amylase and lipase that masked the tiny volume of secretions from the islets of Langerhans. Scientists were certain that these secretions contained the elusive glucose-regulating hormone, but were stymied by how to isolate it from the pancreatic slurry.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ConditionsOpinionRheuminationsSpeak Out Rheum Tagged with:AutoimmuneCharles BestdiabetesdiscoveryDr. Frederick Bantingglucoseinsulinislet cellsPathogenesispatient careTreatment

Related Articles

    Treating Asymptomatic Hyperuricemia Could Lower Risk of Developing Chronic Conditions

    August 12, 2016

    When uric acid becomes elevated in the human body, a variety of problems can develop, most notably gout—a painful, inflammatory arthritis caused by uric acid crystal deposition in joints. Chronically elevated uric acid can also lead to painful kidney stones. The majority of patients found to have hyperuricemia, however, never go on to develop gout…

    Gout, Glucose Metabolism and Obesity: A Case Review

    November 2, 2014

    New research explores association between hyperurecimia and gout with metabolic derangement

    How Energy Shifts Lead to Systemic Illness

    July 12, 2011

    The impact of adaptive energy programs on the manifestations of chronic inflammatory disease

    Early Probiotics Supplementation Tied to Lower Risk of Islet Autoimmunity

    November 12, 2015

    NEW YORK (Reuters Health)—Exposure to probiotics in the first few weeks of life is associated with a reduced risk of islet autoimmunity, according to results from the TEDDY study. “Early supplementation of probiotics may be important but we need more research on this,” Dr. Ulla Uusitalo from University of South Florida in Tampa told Reuters…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences